(0.25%) 5 167.75 points
(0.20%) 38 911 points
(0.23%) 18 043 points
(0.90%) $78.81
(0.05%) $2.14
(0.76%) $2 326.20
(2.55%) $27.37
(1.31%) $977.95
(-0.02%) $0.929
(-0.23%) $10.85
(-0.25%) $0.795
(-0.99%) $90.55
-0.77% € 51.70
Live Chart Being Loaded With Signals
Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services...
Stats | |
---|---|
Объем за сегодня | 262.00 |
Средний объем | 4 215.00 |
Рыночная капитализация | 892.58M |
EPS | €0 ( 2024-03-04 ) |
Дата следующего отчета о доходах | ( €0 ) 2024-05-13 |
Last Dividend | €0.210 ( 2023-05-17 ) |
Next Dividend | €0 ( N/A ) |
P/E | 37.19 |
ATR14 | €0 (0.00%) |
Nexus AG Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Nexus AG Финансовые показатели
Annual | 2023 |
Выручка: | €241.46M |
Валовая прибыль: | €203.06M (84.10 %) |
EPS: | €1.390 |
FY | 2023 |
Выручка: | €241.46M |
Валовая прибыль: | €203.06M (84.10 %) |
EPS: | €1.390 |
FY | 2022 |
Выручка: | €209.13M |
Валовая прибыль: | €176.46M (84.38 %) |
EPS: | €1.210 |
FY | 2021 |
Выручка: | €188.18M |
Валовая прибыль: | €159.10M (84.54 %) |
EPS: | €1.090 |
Financial Reports:
No articles found.
Nexus AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.210 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.100 | 2012-05-24 |
Last Dividend | €0.210 | 2023-05-17 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | €1.860 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.87 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.06 | |
Div. Directional Score | 7.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PAT.DE | Ex Dividend Junior | 2023-05-26 | Sporadic | 0 | 0.00% | |
AEC1.DE | Ex Dividend Knight | 2023-07-06 | Quarterly | 0 | 0.00% | |
H5E.DE | No Dividend Player | 2023-07-10 | Annually | 0 | 0.00% | |
SBS.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
BNP.DE | Ex Dividend Junior | 2023-05-22 | Annually | 0 | 0.00% | |
JNJ.DE | Ex Dividend Knight | 2023-08-25 | Quarterly | 0 | 0.00% | |
TTK.DE | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
CWC.DE | Ex Dividend Knight | 2023-06-08 | Annually | 0 | 0.00% | |
MSF.DE | Ex Dividend Knight | 2023-08-16 | Quarterly | 0 | 0.00% | |
1YD.DE | Ex Dividend Knight | 2023-09-20 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0995 | 1.500 | 8.01 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0584 | 1.200 | 8.05 | 9.67 | [0 - 0.3] |
returnOnEquityTTM | 0.0977 | 1.500 | -0.0252 | -0.0378 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.946 | 0.800 | 5.27 | 4.22 | [1 - 3] |
quickRatioTTM | 1.907 | 0.800 | 3.49 | 2.79 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0492 | -1.500 | 9.18 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 18.39 | 1.000 | 4.30 | 4.30 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.761 | 2.00 | 9.41 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.213 | 2.00 | 9.39 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0794 | -1.500 | 9.68 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.841 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.146 | 1.000 | 9.08 | 9.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.502 | 1.000 | 2.77 | 2.77 | [0.2 - 2] |
assetTurnoverTTM | 0.586 | 0.800 | 9.42 | 7.54 | [0.5 - 2] |
Total Score | 10.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.43 | 1.000 | 6.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0977 | 2.50 | -0.0162 | -0.0378 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.213 | 2.00 | 9.60 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.403 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.761 | 2.00 | 9.41 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.126 | 1.000 | 9.35 | 0 | [0.1 - 0.5] |
Total Score | 4.06 |
Nexus AG
Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа